🇺🇸 FDA
Patent

US 8362060

Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

granted A61KA61K31/4164A61K45/06

Quick answer

US patent 8362060 (Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid) held by Theravance, Inc. expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/4164, A61K45/06, A61P, A61P43/00